Aurobindo arm CuraTeQ gets Brazil regulator ANVISA nod for Hyderabad biosimilars facility | Hyderabad News
Hyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has received approval from Brazil’s National Health Surveillance Agency, ANVISA, for its biosimilars manufacturing facility in Hyderabad.The approval follows a good manufacturing practice inspection conducted by ANVISA from May 11 to May 15, 2026, covering biological active pharmaceutical ingredients and sterile products,…